Valeant Pharmaceuticals International ‘s ( VRX ) third quarter 2012 earnings of $1.11 per share (excluding special items but including stock-based compensation expense) was above
We maintained a Neutral recommendation on KB Home ( KBH ) following appraisal of the third quarter 2012 results. KB Home’s adjusted net loss per share of 10 cents in the third quarter